Symbio Scientific Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 13 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.23 Cr
as on 20-12-2024
- Revenue 47.80%
(FY 2022)
- Profit 143.01%
(FY 2022)
- Ebitda 153.28%
(FY 2022)
- Net Worth 68.67%
(FY 2022)
- Total Assets 5.46%
(FY 2022)
About Symbio Scientific
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.23 Cr.
Debarati Paul and Susanta Paul serve as directors at the Company.
- CIN/LLPIN
U24297DL2011PTC228645
- Company No.
228645
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Symbio Scientific Private Limited offer?
Symbio Scientific Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Electrotherapy Equipment, Pain Relief Drugs & Pharmaceuticals, Pain Killers, Bathroom Accessories, Soap & Sanitizer Dispenser, Laboratory & Lab Equipment, Laboratory Shakers, Plastic & Glass Labware, Laboratory Plates.
Who are the key members and board of directors at Symbio Scientific?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Susanta Paul  | Director | 13-Dec-2011 | Current |
| Debarati Paul | Director | 13-Dec-2011 | Current |
Financial Performance of Symbio Scientific.
Symbio Scientific Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.8% increase. The company also saw a substantial improvement in profitability, with a 143.01% increase in profit. The company's net worth Soared by an impressive increase of 68.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Symbio Scientific?
In 2021, Symbio Scientific had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Oct 2021 | ₹0.55 M | Open |
Hdfc Bank Limited Creation Date: 15 Jun 2021 | ₹0.56 M | Open |
Hdfc Bank Limited Creation Date: 16 Sep 2016 | ₹1.12 Cr | Open |
How Many Employees Work at Symbio Scientific?
Symbio Scientific has a workforce of 4 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symbio Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbio Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
